A study of alpha-adrenoceptor gene polymorphisms and Alzheimer disease

J Neural Transm (Vienna). 2001;108(4):445-50. doi: 10.1007/s007020170065.

Abstract

There exists considerable evidence implicating abnormalities of the alpha (alpha)-adrenergic system in the development of Alzheimer disease (AD). We propose to investigate potential correlations between the presence or otherwise of alpha-adrenoceptor polymorphisms and the presence of AD. We studied the polymorphisms of the alpha1a- and the alpha2a-adrenoceptor genes in 142 AD patients and 98 normal controls. The result demonstrated that none of the alpha2a-adrenoceptor genotypes was associated with increased susceptibility to AD. However, there was a trend that the frequency of the C allele of the alpha1a-adrenoceptor was elevated and an excess of the CC genotype (90.1%) was found in the subjects with AD in comparison with the controls (78.6%). This association was unrelated to the apolipoprotein E genotypes. The hypothesis that the alpha1a-adrenoceptor gene may be implicated in the pathogenesis of AD may deserve further study.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Alzheimer Disease / genetics*
  • Apolipoproteins E / genetics
  • Female
  • Genetic Predisposition to Disease
  • Genotype
  • Humans
  • Male
  • Polymorphism, Genetic*
  • Receptors, Adrenergic, alpha-1 / genetics*
  • Receptors, Adrenergic, alpha-2 / genetics*

Substances

  • Apolipoproteins E
  • Receptors, Adrenergic, alpha-1
  • Receptors, Adrenergic, alpha-2